Search results
You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.
Biopharmaceutical company ProQR is conducting a Phase 2/3 clinical trial (Illuminate) to measure the safety and effectiveness of RNA therapy, Sepofarsen which aims to treat Leber's Congenital Amourosis (LCA) 10.
Aavantgarde Bio Ush1B study at Moorfields
From our newsletters to the recordings of our webinars and everything in-between, use the filters (below) to find the content that's right for you.
Are you affected by inherited sight loss? We are here to help.
The development of a new treatment is a lengthy process, from early investigation of ideas and principles in the lab, through testing in cell and animal models to the final stages of clinical trials in human patients. The good news is that progress is increasingly rapid.
These frequently asked questions should provide a response for most of the queries you might raise.
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
